MedyMatch

Company profile

About MedyMatch

MedyMatch Technology is a medical imaging AI company that leverages deep vision and cognitive analytics to transform emergency room diagnostics. Founded on deep learning and machine vision expertise, the company has developed a generalized AI platform that analyzes the full richness of 3D medical imaging alongside patient-specific data to deliver precise clinical decision support. The platform is designed to help any physician or radiologist recognize conditions that humans and even experienced radiologists might miss, enabling immediate, accurate treatment in acute care settings. The company's technology addresses a critical healthcare challenge: studies show that 30% of medical imaging diagnoses are incorrect, with 80% of those errors being perceptual errors that go unnoticed by the human eye. MedyMatch's AI engine compares billions of data points to identify both rare, long-tail anomalies and common conditions, facilitating acute emergency room treatment rather than life-long management of chronic conditions. MedyMatch has established strategic partnerships with major healthcare technology leaders including IBM Watson Health, GE Healthcare, and Samsung NeuroLogica. The company received FDA Breakthrough Device Designation for its intracranial hemorrhage detection software, accelerating its path to market. Led by Gene Saragnese, former CEO of Philips Imaging Systems, and a team of AI, machine learning, and algorithmic experts, MedyMatch is focused initially on stroke and head trauma detection in emergency departments, with plans to expand into trauma care and chronic neurodegenerative diseases.

Company description · MedyMatch official website